Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

AstraZeneca presents dual CCR3 modulators/histamine H1 antagonists

Sep. 12, 2003

Taisho ends anti-CD23 collaboration

Sep. 10, 2003

Pfizer presents novel PDE4 inhibitors and their use

Sep. 10, 2003

NO blocks platelet-leukocyte aggregate formation in acute respiratory distress syndrome

Sep. 4, 2003

RWJ-58643, a tryptase inhibitor with potential antiasthmatic activity

Sep. 2, 2003

Roxithromycin has antiallergic activity

Sep. 1, 2003

Novel chemokine CCR4 receptor modulators and their use in asthma therapy

Aug. 29, 2003

AD-237 enters phase IIa study for COPD

Aug. 26, 2003

New safety information for salmeterol-based drugs

Aug. 21, 2003

Potent and selective non-imidazole human histamine H4 receptor antagonists

Aug. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...